JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M507681200 on November 28, 2005

J. Biol. Chem., Vol. 281, Issue 5, 2639-2648, February 3, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
281/5/2639    most recent
M507681200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kelley, G. G.
Right arrow Articles by Wojcikiewicz, R. J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kelley, G. G.
Right arrow Articles by Wojcikiewicz, R. J. H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

G-protein-coupled Receptor Agonists Activate Endogenous Phospholipase C{epsilon} and Phospholipase Cbeta3 in a Temporally Distinct Manner*

Grant G. Kelley{ddagger}§1, Katherine A. Kaproth-Joslin{ddagger}§, Sarah E. Reks{ddagger}, Alan V. Smrcka, and Richard J. H. Wojcikiewicz§

From the Departments of {ddagger}Medicine and §Pharmacology, State University of New York Upstate Medical University, Syracuse, New York 13210 and the Department of Pharmacology, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642

Phospholipase C{epsilon} (PLC{epsilon}) is one of the newest members of the phosphatidylinositol-specific phospholipase C (PLC) family. Previous studies have suggested that G-protein-coupled receptors (GPCRs) stimulate phosphoinositide (PI) hydrolysis by activating PLCbeta isoforms through Gq family G proteins and Gbeta{gamma} subunits. Using RNA interference to knock down PLC isoforms, we demonstrate that the GPCR agonists endothelin (ET-1), lysophosphatidic acid (LPA), and thrombin, acting through endogenous receptors, couple to both endogenous PLC{epsilon} and the PLCbeta isoform, PLCbeta3, in Rat-1 fibroblasts. Examination of the temporal activation of these PLC isoforms, however, reveals agonist- and isoform-specific profiles. PLCbeta3 is activated acutely within the first minute of ET-1, LPA, or thrombin stimulation but does not contribute to sustained PI hydrolysis induced by LPA or thrombin and accounts for only part of ET-1 sustained stimulation. PLC{epsilon}, on the other hand, predominantly accounts for sustained PI hydrolysis. Consistent with this observation, reconstitution of PLC{epsilon} in knockdown cells dose-dependently increases sustained, but not acute, agonist-stimulated PI hydrolysis. Furthermore, combined knockdown of both PLC{epsilon} and PLCbeta3 additively inhibits PI hydrolysis, suggesting independent regulation of each isoform. Importantly, ubiquitination of inositol 1,4,5-trisphosphate receptors correlates with sustained, but not acute, activation of PLC{epsilon} or PLCbeta3. In conclusion, GPCR agonists ET-1, LPA, and thrombin activate endogenous PLC{epsilon} and PLCbeta3 in Rat-1 fibroblasts. Activation of these PLC isoforms displays agonist-specific temporal profiles; however, PLCbeta3 is predominantly involved in acute and PLC{epsilon} in sustained PI hydrolysis.


Received for publication, July 15, 2005 , and in revised form, November 23, 2005.

* This work was supported by National Institutes of Health Grants DK56294 (to G. G. K.) and DK49194 (to R. J. H. W.) and American Diabetes Association Physician Scientist Training Award 7-03-PS-01 (K. A. K.-J.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 To whom correspondence should be addressed: Dept. of Medicine, SUNY Upstate Medical University, 750 East Adams St., Syracuse, NY 13210. Tel.: 315-464-5725; Fax: 315-464-5797; E-mail: kelleyg{at}upstate.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
D. P. Morris, B. Lei, Y.-X. Wu, G. A. Michelotti, and D. A. Schwinn
The {alpha}1a-Adrenergic Receptor Occupies Membrane Rafts with Its G Protein Effectors but Internalizes via Clathrin-coated Pits
J. Biol. Chem., February 1, 2008; 283(5): 2973 - 2985.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Yun, A. Moller, S.-K. Chae, W.-P. Hong, Y. J. Bae, D. D. L. Bowtell, S. H. Ryu, and P.-G. Suh
Siah Proteins Induce the Epidermal Growth Factor-dependent Degradation of Phospholipase C{epsilon}
J. Biol. Chem., January 11, 2008; 283(2): 1034 - 1042.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Yun, W.-P. Hong, J. H. Choi, K. S. Yi, S.-K. Chae, S. H. Ryu, and P.-G. Suh
Phospholipase C-{epsilon} Augments Epidermal Growth Factor-dependent Cell Growth by Inhibiting Epidermal Growth Factor Receptor Down-regulation
J. Biol. Chem., January 4, 2008; 283(1): 341 - 349.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Ikuta, H. Edamatsu, M. Li, L. Hu, and T. Kataoka
Crucial Role of Phospholipase C{varepsilon} in Skin Inflammation Induced by Tumor-Promoting Phorbol Ester
Cancer Res., January 1, 2008; 68(1): 64 - 72.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Citro, S. Malik, E. A. Oestreich, J. Radeff-Huang, G. G. Kelley, A. V. Smrcka, and J. H. Brown
Phospholipase C{varepsilon} is a nexus for Rho and Rap-mediated G protein-coupled receptor-induced astrocyte proliferation
PNAS, September 25, 2007; 104(39): 15543 - 15548.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Nomikos, A. Mulgrew-Nesbitt, P. Pallavi, G. Mihalyne, I. Zaitseva, K. Swann, F. A. Lai, D. Murray, and S. McLaughlin
Binding of Phosphoinositide-specific Phospholipase C-{zeta} (PLC-{zeta}) to Phospholipid Membranes: POTENTIAL ROLE OF AN UNSTRUCTURED CLUSTER OF BASIC RESIDUES
J. Biol. Chem., June 1, 2007; 282(22): 16644 - 16653.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
E. De Vuyst, E. Decrock, M. De Bock, H. Yamasaki, C. C. Naus, W. H. Evans, and L. Leybaert
Connexin Hemichannels and Gap Junction Channels Are Differentially Influenced by Lipopolysaccharide and Basic Fibroblast Growth Factor
Mol. Biol. Cell, January 1, 2007; 18(1): 34 - 46.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Zhou, W. Yang, and J. Li
Ca2+- and Protein Kinase C-dependent Signaling Pathway for Nuclear Factor-{kappa}B Activation, Inducible Nitric-oxide Synthase Expression, and Tumor Necrosis Factor-{alpha} Production in Lipopolysaccharide-stimulated Rat Peritoneal Macrophages
J. Biol. Chem., October 20, 2006; 281(42): 31337 - 31347.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. L. Gallegos, M. T. Kunkel, and A. C. Newton
Targeting Protein Kinase C Activity Reporter to Discrete Intracellular Regions Reveals Spatiotemporal Differences in Agonist-dependent Signaling
J. Biol. Chem., October 13, 2006; 281(41): 30947 - 30956.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Lad, B. McHugh, P. S. Hodkinson, A. C. MacKinnon, C. Haslett, M. H. Ginsberg, and T. Sethi
Phospholipase C{epsilon} Suppresses Integrin Activation
J. Biol. Chem., October 6, 2006; 281(40): 29501 - 29512.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. L. Brown, V. R. Jala, S. K. Raghuwanshi, M. W. Nasser, B. Haribabu, and R. M. Richardson
Activation and regulation of platelet-activating factor receptor: role of gi and gq in receptor-mediated chemotactic, cytotoxic, and cross-regulatory signals.
J. Immunol., September 1, 2006; 177(5): 3242 - 3249.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.